Metoclopramide Sandoz

Metoclopramide hydrochloride, the active ingredient in Metoclopramide Sandoz, is a dopamine antagonist (antiemetic, gastroprokinetic) presented as an oral dosage form for oral use. It treats nausea, vomiting and related gastrointestinal motility disorders in adults.

GNH USA supplies Metoclopramide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is employed to manage conditions that involve nausea, vomiting and delayed gastric emptying.

- Nausea and vomiting: reduces the frequency and severity of episodes. - Post‑operative nausea and vomiting: prevents or treats nausea after surgery. - Gastroparesis: enhances gastric motility and alleviates related symptoms. - Gastro‑oesophageal reflux disease (GERD) adjunct: used alongside other agents to improve reflux control.

Metoclopramide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Fatigue: reduced energy and increased tiredness. - Restlessness: an uneasy feeling or inability to stay still. - Diarrhea: loose, frequent stools.

Serious or Rare Side Effects: - Extrapyramidal symptoms: dystonia, akathisia, or other movement disorders. - Tardive dyskinesia: potentially irreversible involuntary movements with long‑term use. - Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and muscle rigidity. - Hyperprolactinemia: elevated prolactin causing galactorrhea or menstrual disturbances.

When prescribing Metoclopramide, clinicians should consider several safety measures.

- Assess neurological status: monitor for extrapyramidal symptoms, especially in the elderly. - Limit duration: avoid use beyond 12 days to reduce risk of tardive dyskinesia. - Use caution in renal impairment: dose adjustment may be required. - Avoid in patients with known hypersensitivity to metoclopramide. - Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C, protect from moisture and light, retain in original packaging.

Metoclopramide can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticholinergic agents: may diminish the prokinetic effect. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase metoclopramide plasma concentrations. - Other dopamine antagonists (e.g., phenothiazines): additive risk of extrapyramidal symptoms.

Moderate Interactions (Monitor Closely): - Opioids: may enhance constipation and sedation. - Serotonergic agents (e.g., ondansetron): potential additive antiemetic effect but increased risk of serotonin syndrome.